[go: up one dir, main page]

AR133115A1 - KRAS INHIBITORS - Google Patents

KRAS INHIBITORS

Info

Publication number
AR133115A1
AR133115A1 ARP240101680A ARP240101680A AR133115A1 AR 133115 A1 AR133115 A1 AR 133115A1 AR P240101680 A ARP240101680 A AR P240101680A AR P240101680 A ARP240101680 A AR P240101680A AR 133115 A1 AR133115 A1 AR 133115A1
Authority
AR
Argentina
Prior art keywords
compound
formula
kras inhibitors
kras
inhibitors
Prior art date
Application number
ARP240101680A
Other languages
Spanish (es)
Inventor
Brian Edward Fink
Pravin S Shirude
Amit Kumar Chattopadhyay
Laxmi Narayan Nanda
Vishweshwaraiah Baligar
Balaji Seshadri
T G Murali Dhar
Li Sun
- Zheng Zhizhen Barbara Qiang
Manoranjan Panda
Maximillian David Palkowit
Sirish Kaushik Lakkaraju
Moloy Banerjee
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AR133115A1 publication Critical patent/AR133115A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de fórmula (1). Un compuesto de fórmula (2). Un compuesto de fórmula (3). Un compuesto de fórmula (4). Un compuesto de fórmula (5). Un compuesto de fórmula (6). Una composición farmacéutica que comprende un compuesto de cualquiera de las reivindicaciones 1 a 39, o una sal farmacéuticamente aceptable del mismo, y uno o más excipientes farmacéuticamente aceptables.A compound of formula (1). A compound of formula (2). A compound of formula (3). A compound of formula (4). A compound of formula (5). A compound of formula (6). A pharmaceutical composition comprising a compound of any one of claims 1 to 39, or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients.

ARP240101680A 2020-02-09 2024-06-28 KRAS INHIBITORS AR133115A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063551905P 2020-02-09 2020-02-09
US202063655965P 2020-06-04 2020-06-04
US202063588239P 2020-10-05 2020-10-05
US202363511455P 2023-06-30 2023-06-30

Publications (1)

Publication Number Publication Date
AR133115A1 true AR133115A1 (en) 2025-08-27

Family

ID=96877919

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP240101680A AR133115A1 (en) 2020-02-09 2024-06-28 KRAS INHIBITORS
ARP240101678A AR133113A1 (en) 2020-02-09 2024-06-28 KRAS INHIBITORS

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP240101678A AR133113A1 (en) 2020-02-09 2024-06-28 KRAS INHIBITORS

Country Status (1)

Country Link
AR (2) AR133115A1 (en)

Also Published As

Publication number Publication date
AR133113A1 (en) 2025-08-27

Similar Documents

Publication Publication Date Title
CO2022012975A2 (en) Biaryl derivatives as inhibitors of yap/taz-tead protein-protein interaction
AR131639A1 (en) KIF18A INHIBITORS AND THEIR USES
AR132007A1 (en) COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K
AR133988A1 (en) RAS-PI3K INHIBITORS AND THEIR USES
AR134265A1 (en) HETEROCYCLES AND THEIR USES
AR128932A1 (en) BCL-XL INHIBITORS
UY40235A (en) HETEROARYL COMPOUNDS FOR PAIN TREATMENT
AR131493A1 (en) MALT1 INHIBITORS
CL2022002817A1 (en) Human immunodeficiency virus replication inhibitors
AR130602A1 (en) TEAD INHIBITORS AND METHODS OF USE THEREOF
AR131906A1 (en) THERAPEUTIC COMPOUNDS
CL2022002490A1 (en) Biaryl derivatives as inhibitors of yap/taz-tead protein-protein interaction
AR133113A1 (en) KRAS INHIBITORS
AR129588A1 (en) KRAS INHIBITORS
AR134453A1 (en) CBL-B INHIBITORS AND METHODS OF THEIR USE
AR132838A1 (en) PRMT5 INHIBITORS AND THEIR USES
AR132764A1 (en) TYK2 INHIBITORS AND THEIR USES
AR133445A1 (en) Piperidinylpyridinylcarbonitrile derivatives as inhibitors of glutamyl-peptide cyclotransferase and glutamyl-peptide-like protein cyclotransferase
AR132166A1 (en) NLRP3 INFLAMMASOME INHIBITORS AND THEIR USES
AR134404A1 (en) THERAPEUTIC COMPOUNDS
MX2024004551A (en) Inhibitors of human immunodeficiency virus replication.
AR130303A1 (en) PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE
AR125934A1 (en) MACROCYCLIC COMPOUNDS TO TREAT DISEASES
MX2022015532A (en) Quinazoline derivatives useful as selective hdac6 inhibitors.
AR133293A1 (en) KV1.3 POTASSIUM CHANNEL ANTAGONISTS